Nightingale grants options to officers



    MARKHAM, ON, Sept. 4 /CNW/ - Nightingale Informatix Corporation
("Nightingale" or the "Company"), an application service provider (ASP) of
electronic medical record (EMR) software and related services with more than
5.3 million patient records under management, announced today that
1,000,000 options have been granted to officers of the Company pursuant to the
Company's employee stock option plan (the "Plan"). Each option under the Plan
is exercisable to acquire one common share at a price of $0.26 per option. The
officers receiving options under this grant are: J.Bradbury, M. Cameron,
M.Ford, A. Kriss, L.Loesch, A. Mourtada, A. Richard, N. Vaney and D. Watt. The
options granted have been approved by the Board of Directors and are subject
to expire on September 2, 2013.

    About Nightingale

    Nightingale is one of the fastest growing healthcare service and software
companies in North America with over 5.3 million patient records under
management in a hosted (ASP) environment. It is recognized as an industry
leader in Web-based clinician and community based electronic medical records
(EMR) serving the needs of small primary care practices, multi-physician
outpatient clinics, and large scale regional health organizations and
networks. Coupled with integrated practice management, transcription and
revenue cycle management, Nightingale's comprehensive service offering allows
customers to enhance patient care, increase revenue opportunities and optimize
operations. Nightingale is continuously innovating and enhancing its services
to meet the needs of its growing and diverse customer base. Nightingale -
Healthcare connected. www.nightingale.md

    Forward Looking Statement

    This press release contains "forward-looking statements" within the
meaning of applicable Canadian securities legislation. Generally,
forward-looking statements can be identified by the use of forward-looking
terminology such as "plans", "expects" or "does not expect", "is expected",
"budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or
"does not anticipate", or "believes", or variations of such words and phrases
or state that certain actions, events or results "may" ,"could", "would",
"might" or "will be taken", "occur" or "be achieved". Forward-looking
statements are subject to known and unknown risks, uncertainties and other
factors that may cause the actual results, level of activity, performance or
achievements of Nightingale to be materially different from those expressed or
implied by such forward-looking statements, including but not limited to:
risks related to the speculative nature of the medical software industry,
which is affected by numerous factors beyond Nightingale's control; the
ability of Nightingale to successfully integrate its acquisitions and any
liabilities arising as a result of such acquisitions; the existence of present
and possible future government regulation; the significant and increasing
competition that exists in the medical software industry; the early stage of
Nightingale's business; and therefore it is subject to the risks associated
with early stage companies, including uncertainty of revenues, markets and
profitability and the need to raise additional capital.
    Although Nightingale has attempted to identify important factors that
could cause actual results to differ materially from those contained in
forward-looking statements, there may be other factors that cause results not
to be as anticipated, estimated or intended. There can be no assurance that
such statements will prove to be accurate, as actual results and future events
could differ materially from those anticipated in such statements.
Accordingly, readers should not place undue reliance on forward-looking
statements. Nightingale does not undertake to update any forward-looking
statements that are incorporated by reference herein, except in accordance
with applicable securities laws. Further information on Nightingale Informatix
Corporation is available at www.sedar.com.

    
    The TSX Venture Exchange has not reviewed and does not accept
    responsibility for the adequacy or accuracy of this release
    

    %SEDAR: 00022709E




For further information:

For further information: Michael Ford, CFO, Nightingale Informatix
Corporation, Tel: (905) 307-7870, mford@nightingale.md; Dave Mason, Investor
Relations, The Equicom Group, Tel: (416) 815-0700 x237, Email:
dmason@equicomgroup.com

Organization Profile

Nightingale Informatix Corporation

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890